3d Printed Drugs Market Scope And Analysis

  • Report Code : TIPRE00010199
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

3D Printed Drugs Market Size and Scope by 2031

Buy Now

3D Printed Drugs Market Report 3D Printed Drugs Market Size and Share 3D Printed Drugs Market Scope and Analysis

3D Printed Drugs Market Report Scope

Report Attribute Details
Market size in 2023 US$ 33.58 Million
Market Size by 2031 US$ 83.08 Million
Global CAGR (2023 - 2031) 9.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Dosage Forms
  • Tablets
  • Capsules
  • Multi Drug Implant
  • Nanoparticles
  • Solutions
By Technology
  • Inkjet Printing
  • Direct Write
  • Zip Dose
  • Thermal Inkjet Printing
  • Fused Deposition Modeling
  • Powder Bed Printing
  • Stereolithography
  • Semi Solid Extrusion
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • APRECIA PHARMACEUTICALS LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GLAXOSMITHKLINE PLC
  • ASTRAZENECA
  • Tvasta
  • Merck KGGA
    		•